The Drug-Coated Balloons Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Drug-Coated Balloons Market:
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

According to The Business Research Company’s Drug-Coated Balloons Global Market Report 2024, The drug-coated balloons market size has grown rapidly in recent years. It will grow from $0.95 billion in 2023 to $1.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology..

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives.. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches..

The rise in the prevalence of coronary artery disease is expected to propel the growth of the drug-coated balloons market going forward. Coronary artery disease (CAD) is a medical condition defined by the narrowing or obstruction of the coronary arteries, that feed blood to the heart muscle, leading to heart attacks. The drug-coated balloon is a medical device used in the treatment of coronary artery disease. The drug is released into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery after angioplasty. For instance, in May 2023, according to the report published by the Centers for Disease Control and Prevention, a US-based national public health agency, the coronary heart disease, in United States, increased to 375,476 deaths in 2021 and about 1 in 20 adults aged 20 and older have coronary heart disease. Thus, the rise in the prevalence of coronary artery disease is expected to boost the drug-coated balloon market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

The drug-coated balloons market covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel, Sirolimus
3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Product innovations are a key trend gaining popularity in the drug-coated balloons market. Major companies operating in the drug-coated balloons market are focused on developing new technological and innovative solutions to strengthen their position in the market. For instance, in July 2021, Medtronic plc, a US-based provider of medical devices, launched the Prevail drug coated balloon (DCB) Catheter. This cutting-edge tool is used in percutaneous coronary intervention (PCI) operations to treat patients with coronary artery disease (CAD) who have blocked or constricted coronary arteries. It delivers focused therapy to the blockage location using paclitaxel, a medication with fast absorption. This enables effective treatment of many kinds of lesions, such as in-stent restenosis (ISR), small vascular disease, and de novo lesions.

The drug-coated balloons market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Major Players:

Acotec Scientific AG
AR Baltic Medical AB
B. Braun Melsungen AG
Becton Dickinson and Company
Biosensors International Group Ltd.

Related Reports:
https://goodprnews.com/blueberry-extract-market/
https://goodprnews.com/beta-blockers-drugs-market-insights/
https://topprnews.com/blueberry-extract-market-size/
https://topprnews.com/beta-blockers-market/


Contact Us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model